N/A
N=218
Utilizing Text Messaging to Improve Vehicle Safety Among At-Risk Young Adults
Risk Reduction
Bottom Line
View on ClinicalTrials.gov: NCT03833713 ↗Enrolled (actual)
218
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcome: Primary: Seat Belt Use — 34; 15 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- SMS Dialogue (Behavioral); SMS Assessments (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Pittsburgh
- Primary completion
- Nov 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Seat Belt Use |
32; 20 | — |
| SECONDARY Feasibility of Recruitment |
218 | — |
| SECONDARY Measure of Intervention Acceptability |
56; 59 | — |
| SECONDARY Seat Belt Use |
32; 20 | — |
Summary
The "Safe Vehicle Engagement (SaVE)" trials are 3 parallel randomized clinical trials that aim to determine the impact of text messaging (SMS) vehicle safety interventions vs. weekly SMS vehicle safety self-monitoring alone on seat belt use, distracted driving and drink driving among young adults identified in the emergency department (ED) with risky vehicle behaviors.
Eligibility Criteria
Inclusion criteria
- Adult participant (age ≥ 18 years & ≤25 years)
- Cohort 1: Any vehicle trip in past 2 weeks where individual reports not using a seat belt
- Cohort 2: Any vehicle trip in past 2 weeks where individual reports phone was used to type while driving and car was moving
- Cohort 3: Any vehicle trip in past 2 weeks where individual reports driving a vehicle within 2 hours after consuming 2 or more drinks
Exclusion criteria
- Member of a protected population (prisoner)
- Unable to provide informed consent
- No plan to drive and/or ride in a vehicle in the next month
- Non-English speaking
- No personal mobile phone or planning on changing phone in next 3 months
Data sourced from ClinicalTrials.gov (NCT03833713). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.